Unweighted models – baseline covariates |
Unweighted models – baseline covariates and time-varying covariates |
Weighted models – baseline covariates |
|
---|---|---|---|
Tuberculosis | 0.77 (0.65,0.91) | 0.95 (0.80,1.12) | 0.48 (0.36,0.64) |
MAC | 1.12 (0.75,1.69) | 1.25 (0.84,1.86) | 0.51 (0.27,0.95) |
CMV Retinitis | 0.86 (0.52,1.42) | 0.95 (0.58,1.54) | 0.24 (0.09,0.66) |
PML | 1.04 (0.63,1.72) | 1.03 (0.63,1.67) | 0.41 (0.15,1.09) |
Herpes Simplex Infection | 0.97 (0.78,1.19) | 1.09 (0.88,1.34) | 0.76 (0.58,1.00) |
Kaposi Sarcoma | 0.53 (0.44,0.64) | 0.84 (0.70,1.02) | 0.22 (0.15,0.32) |
Non Hodgkin Lymphoma | 0.88 (0.69,1.11) | 0.94 (0.74,1.20) | 0.51 (0.36,0.73) |
Cryptococcosis | 0.46 (0.30,0.70) | 0.57 (0.38,0.87) | 0.15 (0.05,0.42) |
Candidiasis | 0.43 (0.34,0.54) | 0.73 (0.58,0.90) | 0.18 (0.12,0.26) |
cART Combined antiretroviral therapy; CMV cytomegalovirus; MAC Mycobacterium avium complex; PML Progressive multifocal leukoencephalopathy.